NCT00257166 - Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) | Biotech Hunter

Enrollment

238

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Bipolar Disorder

Interventions

DRUG

Ziprasidone oral capsules

Oral ziprasidone capsules of 20 mg, 40 mg, 60 mg, and 80 mg strength administered BID.

DRUG

placebo oral capsules

Oral placebo capsules of 20 mg, 40 mg, 60 mg, and 80 mg strength administered BID.

Trial Locations (50)

14215

Pfizer Investigational Site, Buffalo

14618

Pfizer Investigational Site, Rochester

21204

Pfizer Investigational Site, Towson

21208

Pfizer Investigational Site, Pikesville

21286

Pfizer Investigational Site, Towson

29405

Pfizer Investigational Site, Charleston

30033

Pfizer Investigational Site, Decatur

32701

Pfizer Investigational Site, Altamonte Springs

32763

Pfizer Investigational Site, Orange City

32778

Pfizer Investigational Site, Tavares

33161

Pfizer Investigational Site, North Miami

33301

Pfizer Investigational Site, Fort Lauderdale

39301

Pfizer Investigational Site, Meridian

40509

Pfizer Investigational Site, Lexington

42301

Pfizer Investigational Site, Owensboro

43210

Pfizer Investigational Site, Columbus

45224

Pfizer Investigational Site, Cincinnati

45229

Pfizer Investigational Site, Cincinnati

47802

Pfizer Investigational Site, Terre Haute

48038

Pfizer Investigational Site, Clinton Township

53226

Pfizer Investigational Site, Milwaukee

53227

Pfizer Investigational Site, West Allis

60016

Pfizer Investigational Site, Des Plaines

60194

Pfizer Investigational Site, Schaumburg

68131

Pfizer Investigational Site, Omaha

68510

Pfizer Investigational Site, Lincoln

70809

Pfizer Investigational Site, Baton Rouge

71103

Pfizer Investigational Site, Shreveport

73101

Pfizer Investigational Site, Oklahoma City

73107

Pfizer Investigational Site, Oklahoma City

73112

Pfizer Investigational Site, Oklahoma City

73116

Pfizer Investigational Site, Oklahoma City

74114

Pfizer Investigational Site, Tulsa

75093

Pfizer Investigational Site, Plano

75115

Pfizer Investigational Site, DeSoto

76011

Pfizer Investigational Site, Arlington

76102

Pfizer Investigational Site, Fort Worth

77566

Pfizer Investigational Site, Lake Jackson

78229

Pfizer Investigational Site, San Antonio

80218

Pfizer Investigational Site, Denver

85251

Pfizer Investigational Site, Scottsdale

87102

Pfizer Investigational Site, Albuquerque

92123

Pfizer Investigational Site, San Diego

92868

Pfizer Investigational Site, Orange

96826

Pfizer Investigational Site, Honolulu

98033

Pfizer Investigational Site, Kirkland

99204

Pfizer Investigational Site, Spokane

63044-2588

Pfizer Investigational Site, St Louis

45267-0559

Pfizer Investigational Site, Cincinnati

44106-5080

Pfizer Investigational Site, Cleveland

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY